Skip to content
Disclosery

EXANE DERIVATIVES: SNA position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on SNA, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 330 SNA shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 330 shares
    Change vs previous 13F -39 shares

    0.04% of the 13F portfolio, value $65,007.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 369 shares
    Change vs previous 13F +28 shares

    0.02% of the 13F portfolio, value $75,817.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 341 shares
    Change vs previous 13F +16 shares

    0.02% of the 13F portfolio, value $73,442.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 325 shares
    Change vs previous 13F -86 shares

    0.02% of the 13F portfolio, value $67,906.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 411 shares
    Change vs previous 13F -165 shares

    0.02% of the 13F portfolio, value $91,861.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 576 shares
    Change vs previous 13F -59 shares

    0.04% of the 13F portfolio, value $132,900.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 635 shares
    Change vs previous 13F +455 shares

    0.03% of the 13F portfolio, value $108,669.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 180 shares
    Change vs previous 13F not available

    0.01% of the 13F portfolio, value $26,482.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).